NIOX Group Plc

Equities

CIR

GB00BJVD3B28

Pharmaceuticals

Delayed London S.E. 12:35:03 2024-03-28 pm EDT 5-day change 1st Jan Change
64 GBX 0.00% Intraday chart for NIOX Group Plc 0.00% -4.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend AN
Earnings Flash (NIOX.L) NIOX GROUP Reports FY23 Revenue GBP36.8M MT
Earnings Flash (NIOX.L) NIOX GROUP Posts FY23 EPS GBX2.38 MT
NIOX Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ZEPHYRx and NIOX Announce to Work Together to Advance Respiratory Clinical Research CI
XP Factory revenue doubles; Zotefoams trades in line AN
EARNINGS: Andrews Sykes revenue up; Safestay optimistic AN
NIOX Group Plc Reports Earnings Results for the Half Year Ended June 30, 2023 CI
FTSE Closes Tuesday Up 0.6% Lifted by Banks, Oil Stocks; Ocado Soars DJ
UK Consumers Cut Spending Amid Rising Mortgage Rates DJ
AIM WINNERS & LOSERS: Pelatro reports customer payment delays AN
NIOX shares up as rising half-year revenue driven by Clinical results AN
NIOX Group Plc Announces Special Dividend, Payable on 15 September 2023 CI
FTSE 100 Closes Slightly Down as Property Stocks Slip on House-Prices Data DJ
NIOX declares special dividend and says more payouts to come AN
UK Inflation to Be Among Highest in Major Economies in 2023, OECD Says DJ
NIOX Group Plc Announces Special Dividend, Payable on 15 September 2023 CI
TheWorks.co.uk reports "resilient" annual performance AN
Niox swings to profit in 2022; ScS loss balloons AN
Earnings Flash (NIOX.L) NIOX GROUP Reports FY22 Revenue GBP31.3M MT
Earnings Flash (NIOX.L) NIOX GROUP Posts FY22 EPS GBX3.19 MT
NIOX Group Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NIOX Group Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
FTSE 100 Closes Down 0.1% Amid AstraZeneca, Unilever Weakness DJ
TRADING UPDATES: Quiz profit to be in line with guidance AN
Chart NIOX Group Plc
More charts
NIOX Group plc is a United Kingdom-based diagnostics and management company that is focused on asthma. The Company's product NIOX uses patented technology to measure fractional exhaled nitric oxide (FeNO). Its NIOX FeNO measurement and monitoring products are used by physicians around the globe to help improve asthma diagnosis and management. The Company offers NIOX VERO, a point of care device for the accurate measurement of nitric oxide (NO) as a biomarker of airway inflammation to help diagnose and manage asthma. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company offers products and services in around 50 countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.64 GBP
Average target price
0.76 GBP
Spread / Average Target
+18.75%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock NIOX Group Plc - London S.E.
  4. News NIOX Group Plc
  5. Circassia : Earnings Flash (CIR.L) CIRCASSIA GROUP Posts H1 EPS GBP0.00